Guj. Themis Bio.

{
  "main_header": {
    "sid": 925632,
    "name": "Guj. Themis Bio.",
    "stock_name": "Guj. Themis Bio.",
    "full_name": "Gujarat Themis Biosyn Ltd",
    "name_url": "stocks-analysis/guj-themis-bio",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "324.90",
    "chg": -3.8,
    "chgp": "-1.16%",
    "dir": -1,
    "prev_price": "328.70",
    "mcapval": "3,477.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 506879,
    "symbol": "GUJTHEM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE942C01045",
    "curr_date": "Feb 06",
    "curr_time": "",
    "bse_nse_vol": "31.08 k",
    "exc_status": "Active",
    "traded_date": "Feb 06, 2026",
    "traded_date_str": "2026 02 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/guj-themis-bio-925632-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Gujarat Themis Biosyn Gains 0.57%: 2 Key Factors Driving This Week’s Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gujarat-themis-biosyn-gains-057-2-key-factors-driving-this-weeks-volatility-3826222",
        "imagepath": "",
        "date": "2026-02-07 14:04:54",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Feb:</strong> Stock opens lower amid broader market weakness</p>\n                    <p><strong>3 Feb:</strong> Significant gap up opening at Rs.331.55 (+10.55% intraday)</p>\n                    <p><strong>5 Feb:</strong> Q3 FY26 results reveal margin pressures despite sales recovery</p>\n                    <p><strong>6 Feb:</strong> Week closes at Rs.324.85, consolidating recent volatility</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.319.30</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"st..."
      },
      {
        "title": "Are Gujarat Themis Biosyn Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-gujarat-themis-biosyn-ltd-latest-results-good-or-bad-3824860",
        "imagepath": "",
        "date": "2026-02-06 19:25:04",
        "description": "Gujarat Themis Biosyn Ltd's latest financial results for Q3 FY26 present a complex picture of operational performance. The company reported net sales of ₹43.37 crores, reflecting a sequential growth of 2.41% and a year-on-year increase of 9.74%. This indicates a continued demand for its specialty pharmaceutical products and effective market strategies. However, the net profit for the quarter was ₹12.46 crores, which represents a contraction of 12.63% compared to the previous quarter and a decline of 3.93% year-on-year. This divergence between sales growth and profit decline suggests challenges in translating revenue into profitability, raising concerns about operational efficiency and cost management.\n\nThe operating margin stood at 49.14%, which, while still strong, reflects a slight sequential decline of 33 basis points. The PAT margin saw a more significant compression, dropping to 28.73% from 33.67% in t..."
      },
      {
        "title": "Gujarat Themis Biosyn Q3 FY26: Margin Pressures Test Premium Valuation Despite Sales Recovery",
        "link": "https://www.marketsmojo.com/news/result-analysis/gujarat-themis-biosyn-q3-fy26-margin-pressures-test-premium-valuation-despite-sales-recovery-3823003",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/GujaratThemisBi_quaterlyResult_3823003.png",
        "date": "2026-02-05 18:03:41",
        "description": "Gujarat Themis Biosyn Ltd., a speciality pharmaceutical manufacturer, reported net profit of ₹12.46 crores for Q3 FY26 (October-December 2025), marking a 12.63% decline quarter-on-quarter but a 3.93% decline year-on-year. With a market capitalisation of ₹3,609 crores, the small-cap pharma company faces mounting concerns over profitability sustainability despite achieving its highest quarterly revenue run-rate. The stock has declined 1.77% following the results disclosure, currently trading at ₹328.00 and reflecting broader investor unease about the company's ability to justify its premium 74x price-to-earnings multiple."
      },
      {
        "title": "Gujarat Themis Biosyn Ltd Opens Strong with Significant Gap Up Amid Positive Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gujarat-themis-biosyn-ltd-opens-strong-with-significant-gap-up-amid-positive-market-sentiment-3818557",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/GujaratThemisBi_gapup_3818557.png",
        "date": "2026-02-03 12:20:38",
        "description": "Gujarat Themis Biosyn Ltd commenced trading on 3 Feb 2026 with a significant gap up, opening 10.55% higher than its previous close, signalling a robust start amid positive market sentiment in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Gujarat Themis Biosyn Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gujarat-themis-biosyn-ltd-is-rated-sell-3816356",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/GujaratThemisBi_mojoScore_3816356.png",
        "date": "2026-02-02 10:10:04",
        "description": "Gujarat Themis Biosyn Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 February 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "When is the next results date for Gujarat Themis Biosyn Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-gujarat-themis-biosyn-ltd-3815053",
        "imagepath": "",
        "date": "2026-02-01 23:16:00",
        "description": "The next results date for Gujarat Themis Biosyn Ltd is scheduled for February 5, 2026...."
      },
      {
        "title": "Gujarat Themis Biosyn Ltd Falls 11.60%: 7 Key Factors Driving the Weekly Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gujarat-themis-biosyn-ltd-falls-1160-7-key-factors-driving-the-weekly-decline-3803398",
        "imagepath": "",
        "date": "2026-01-24 14:06:22",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Jan 19:</strong> Stock opens at Rs.360.60 with mild gains amid sideways technical signals</p>\n                    <p><strong>Jan 20:</strong> Intraday low hit at Rs.332.20 amid heavy price pressure and rating upgrade to Hold</p>\n                    <p><strong>Jan 21:</strong> Price declines sharply with mixed technical signals, closing at Rs.315.35</p>\n                    <p><strong>Jan 22:</strong> Brief recovery with 8.07% gain to Rs.340.80, but technical downgrade follows</p>\n                    <p><strong>Jan 23:</strong> Intraday volatility leads to a low of Rs.316.30 and close at Rs.315.65, rating downgraded to Sell</p>\n                </div>\n\n                <div class=\"sta..."
      },
      {
        "title": "Gujarat Themis Biosyn Ltd Hits Intraday Low Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gujarat-themis-biosyn-ltd-hits-intraday-low-amid-price-pressure-3801889",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/GujaratThemisBi_priceRelatedfactors_3801889.png",
        "date": "2026-01-23 13:31:37",
        "description": "Shares of Gujarat Themis Biosyn Ltd declined sharply on 23 Jan 2026, hitting an intraday low of Rs 316.3, reflecting significant price pressure amid a broadly negative market environment and heightened volatility."
      },
      {
        "title": "Gujarat Themis Biosyn Ltd Faces Mixed Technical Signals Amid Bearish Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gujarat-themis-biosyn-ltd-faces-mixed-technical-signals-amid-bearish-momentum-shift-3801018",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/GujaratThemisBi_technicaldot_3801018.png",
        "date": "2026-01-23 08:01:46",
        "description": "Gujarat Themis Biosyn Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a strong daily price gain of 6.96%, the stock’s technical indicators present a complex picture, with mixed signals across weekly and monthly timeframes, prompting a downgrade in its Mojo Grade from Hold to Sell as of 21 January 2026."
      }
    ],
    "total": 355,
    "sid": "925632",
    "stock_news_url": "https://www.marketsmojo.com/news/gujarat-themis-biosyn-925632"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "06-Feb-2026",
      "details": "Please refer to the attachment",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)",
      "datetime": "05-Feb-2026",
      "details": "The Board of Directors at its meeting held today have inter alia transacted the following items of businesses: a) Approved the Unaudited Financial Results for the quarter and nine months ended 31st December 2025 b) The Board on the recommendation of the Nomination & Remuneration Committee has approved the re-appointment of Ms. Kirandeep Madan (DIN: 00686547) as Non-Executive Woman Independent Director of the Company c) Considering the functional requirements of the Company Mr. Bhavik Shah Chief Financial Officer is transitioning into a different role within the organization. Based on the recommendation of the Nomination & Remuneration Committee and in order to strengthen the finance function the Board approved the appointment of Mr. Krupesh Patel as Chief Financial Officer & Key Managerial Personnel of the Company",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "05-Feb-2026",
      "details": "Please refer to the attachment.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Gujarat Themis Biosyn Ltd has declared <strong>67%</strong> dividend, ex-date: 04 Sep 25",
          "dt": "2025-09-04",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Gujarat Themis Biosyn Ltd has announced <strong>1:5</strong> stock split, ex-date: 10 Oct 23",
          "dt": "2023-10-10",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Gujarat Themis Biosyn Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 09 Aug 24",
          "dt": "2024-08-09",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Gujarat Themis Biosyn Gains 0.57%: 2 Key Factors Driving This Week’s Volatility

2026-02-07 14:04:54

Key Events This Week

2 Feb: Stock opens lower amid broader market weakness

3 Feb: Significant gap up opening at Rs.331.55 (+10.55% intraday)

5 Feb: Q3 FY26 results reveal margin pressures despite sales recovery

6 Feb: Week closes at Rs.324.85, consolidating recent volatility

Week Open

Rs.319.30

Week Close

Read full news article

Are Gujarat Themis Biosyn Ltd latest results good or bad?

2026-02-06 19:25:04

Gujarat Themis Biosyn Ltd's latest financial results for Q3 FY26 present a complex picture of operational performance. The company reported net sales of ₹43.37 crores, reflecting a sequential growth of 2.41% and a year-on-year increase of 9.74%. This indicates a continued demand for its specialty pharmaceutical products and effective market strategies. However, the net profit for the quarter was ₹12.46 crores, which represents a contraction of 12.63% compared to the previous quarter and a decline of 3.93% year-on-year. This divergence between sales growth and profit decline suggests challenges in translating revenue into profitability, raising concerns about operational efficiency and cost management. The operating margin stood at 49.14%, which, while still strong, reflects a slight sequential decline of 33 basis points. The PAT margin saw a more significant compression, dropping to 28.73% from 33.67% in t...

Read full news article

Gujarat Themis Biosyn Q3 FY26: Margin Pressures Test Premium Valuation Despite Sales Recovery

2026-02-05 18:03:41

Gujarat Themis Biosyn Ltd., a speciality pharmaceutical manufacturer, reported net profit of ₹12.46 crores for Q3 FY26 (October-December 2025), marking a 12.63% decline quarter-on-quarter but a 3.93% decline year-on-year. With a market capitalisation of ₹3,609 crores, the small-cap pharma company faces mounting concerns over profitability sustainability despite achieving its highest quarterly revenue run-rate. The stock has declined 1.77% following the results disclosure, currently trading at ₹328.00 and reflecting broader investor unease about the company's ability to justify its premium 74x price-to-earnings multiple.

Read full news article

Gujarat Themis Biosyn Ltd Opens Strong with Significant Gap Up Amid Positive Market Sentiment

2026-02-03 12:20:38

Gujarat Themis Biosyn Ltd commenced trading on 3 Feb 2026 with a significant gap up, opening 10.55% higher than its previous close, signalling a robust start amid positive market sentiment in the Pharmaceuticals & Biotechnology sector.

Read full news article

Gujarat Themis Biosyn Ltd is Rated Sell

2026-02-02 10:10:04

Gujarat Themis Biosyn Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 February 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

When is the next results date for Gujarat Themis Biosyn Ltd?

2026-02-01 23:16:00

The next results date for Gujarat Themis Biosyn Ltd is scheduled for February 5, 2026....

Read full news article

Gujarat Themis Biosyn Ltd Falls 11.60%: 7 Key Factors Driving the Weekly Decline

2026-01-24 14:06:22

Key Events This Week

Jan 19: Stock opens at Rs.360.60 with mild gains amid sideways technical signals

Jan 20: Intraday low hit at Rs.332.20 amid heavy price pressure and rating upgrade to Hold

Jan 21: Price declines sharply with mixed technical signals, closing at Rs.315.35

Jan 22: Brief recovery with 8.07% gain to Rs.340.80, but technical downgrade follows

Jan 23: Intraday volatility leads to a low of Rs.316.30 and close at Rs.315.65, rating downgraded to Sell

Read full news article

Gujarat Themis Biosyn Ltd Hits Intraday Low Amid Price Pressure

2026-01-23 13:31:37

Shares of Gujarat Themis Biosyn Ltd declined sharply on 23 Jan 2026, hitting an intraday low of Rs 316.3, reflecting significant price pressure amid a broadly negative market environment and heightened volatility.

Read full news article

Gujarat Themis Biosyn Ltd Faces Mixed Technical Signals Amid Bearish Momentum Shift

2026-01-23 08:01:46

Gujarat Themis Biosyn Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a strong daily price gain of 6.96%, the stock’s technical indicators present a complex picture, with mixed signals across weekly and monthly timeframes, prompting a downgrade in its Mojo Grade from Hold to Sell as of 21 January 2026.

Read full news article

View All News